Tuesday, May 11, 2021
At Home Genetic Testing for Breast and Ovarian Cancer Risk
This question plus determining the feasibility of doing remote testing are being examined in the Magenta (Making GENetic Testing Accessible) study of 4,000 women participating in all 50 states.
Given the lack of good screening tools for OC, some women, especially those in more rural areas, with strong family histories of breast or ovarian cancer may feel more empowered to make pro-active decisions about undergoing prophylactic surgery rather than live with the fear of possibly getting cancer. To find out more about study, follow this link.